These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10596360)

  • 41. Formulation and evaluation of ubidecarenone transdermal delivery systems.
    Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
    Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
    J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of electrical and chemical factors on transdermal iontophoretic delivery of three diclofenac salts.
    Fang JY; Wang RJ; Huang YB; Wu PC; Tsai YH
    Biol Pharm Bull; 2001 Apr; 24(4):390-4. PubMed ID: 11305601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of different penetration enhancers on diclofenac permeation across horse skin.
    Ferrante M; Andreeta A; Landoni MF
    Vet J; 2010 Dec; 186(3):312-5. PubMed ID: 19815433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
    Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
    Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cyclic monoterpenes on percutaneous absorption in the case of a water-soluble drug (diclofenac sodium).
    Obata Y; Takayama K; Okabe H; Nagai T
    Drug Des Deliv; 1990 Oct; 6(4):319-28. PubMed ID: 2083031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Passive and iontophoretic delivery of three diclofenac salts across various skin types.
    Fang J; Wang R; Huang Y; Wu PC; Tsai Y
    Biol Pharm Bull; 2000 Nov; 23(11):1357-62. PubMed ID: 11085366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of microporation on passive and iontophoretic delivery of diclofenac sodium.
    Patel H; Joshi A; Joshi A; Stagni G
    Drug Dev Ind Pharm; 2015; 41(12):1962-7. PubMed ID: 25758411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diclofenac phonophoresis in human volunteers.
    Rosim GC; Barbieri CH; Lanças FM; Mazzer N
    Ultrasound Med Biol; 2005 Mar; 31(3):337-43. PubMed ID: 15749556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy.
    Fligner CL; Jack R; Twiggs GA; Raisys VA
    JAMA; 1985 Mar; 253(11):1606-9. PubMed ID: 3974044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic profile of a new matrix-type transdermal delivery system: diclofenac diethyl ammonium patch.
    Devi K; Paranjothy KL
    Drug Dev Ind Pharm; 1999 May; 25(5):695-700. PubMed ID: 10219542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elastic liposomes-in-vehicle formulations destined for skin therapy: the synergy between type of liposomes and vehicle.
    Palac Z; Hurler J; Škalko-Basnet N; Filipović-Grčić J; Vanić Ž
    Drug Dev Ind Pharm; 2015; 41(8):1247-53. PubMed ID: 25019501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
    Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
    Gwak HS; Chun IK
    Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of formulations variables on the in vitro percutaneous permeation of Sodium Diclofenac from new vesicular systems obtained from Pluronic triblock copolymers.
    Tavano L; Muzzalupo R; Trombino S; Cassano R; Pingitore A; Picci N
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):227-34. PubMed ID: 20434891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
    Maiti S; Kaity S; Ray S; Sa B
    Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxypropyl-β-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium.
    Yan Y; Xing J; Xu W; Zhao G; Dong K; Zhang L; Wang K
    Int J Pharm; 2014 Oct; 474(1-2):182-92. PubMed ID: 25138253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.